Skip to main content
Year archive

Abliva — 2017 filings

All 63 regulatory filings released by Abliva (ABLI) in 2017, sourced directly from the official regulator.

63 Filings
2017 Period
2017 filings (63)
Filing Released Lang
NeuroVives KL1333-program beviljas särläkemedelsklassificering av den Europeiska Kommissionen
Regulatory Filings
2017-12-13 Swedish
NeuroVive’s KL1333 program granted orphan drug designation by the European Commission
Regulatory Filings
2017-12-13 English
NeuroVive reports promising progress in its clinical project for genetic mitochondrial diseases, KL1333
Regulatory Filings
2017-12-11 English
NeuroVive rapporterar lovande framsteg i sitt kliniska projekt för genetiska mitokondriella sjukdomar, KL1333
Regulatory Filings
2017-12-11 Swedish
Amended number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-11-30 English
Ändring av antal aktier och röster i NeuroVive Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-11-30 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-11-21 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-11-21 English
NeuroVives kliniska utvecklingsprojekt KL1333 får positivt utlåtande om europeisk Orphan Drug Designation
Regulatory Filings
2017-11-08 Swedish
NeuroVive’s Clinical Development Project KL1333 Receives Positive Opinion on European Orphan Drug Designation
Regulatory Filings
2017-11-08 English
NeuroVive Board Chair Resigns, New Chair Elected
Board/Management Information
2017-11-07 English
NeuroVives styrelseordförande avgår, ny ordförande vald
Board/Management Information
2017-11-07 Swedish
NeuroVive genomför en riktad nyemission om 5,3 miljoner SEK
Share Issue/Capital Change
2017-11-03 Swedish
NeuroVive conducts a directed new share issue of SEK 5.3 Million
Share Issue/Capital Change
2017-11-03 English
NeuroVive tecknar samarbetsavtal med University of Florida om biomarkörutveckling för TBI
Regulatory Filings
2017-10-31 Swedish
NeuroVive signs collaboration agreement with University of Florida for TBI biomarker development
Regulatory Filings
2017-10-31 English
NeuroVive får positivt besked från vetenskaplig rådgivning med EMA avseende utvecklingsplanen för NeuroSTAT för TBI
Regulatory Filings
2017-09-21 Swedish
NeuroVive receives positive EMA Scientific Advice on its NeuroSTAT development plan for TBI
Regulatory Filings
2017-09-21 English
Interim / Quarterly Report 2017
Interim / Quarterly Report H1 2017
2017-08-17 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report H2 2017
2017-08-17 English
Number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Share Issue/Capital Change
2017-07-31 English
Antal aktier och röster i NeuroVive Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-07-31 Swedish
NeuroVive tecknar private placement-avtal med Esousa Holdings LLC och genomför den första emissionen av Units
Share Issue/Capital Change
2017-07-18 Swedish
NeuroVive signs private placement agreement with Esousa Holdings LLC and issues units
Share Issue/Capital Change
2017-07-18 English
EQS-News: Edison Investment Research Limited: Edison issues initiation on NeuroVive Pharmaceutical (NVP)
Regulatory Filings Q1 2017
2017-06-29 English
NeuroVive and Yungjin Pharm start clinical development in genetic mitochondrial disease
Regulatory Filings
2017-06-27 English
NeuroVive och Yungjin Pharm inleder klinisk utveckling i genetiska mitokondriella sjukdomar
Regulatory Filings
2017-06-27 Swedish
NeuroVive receives research grant from Vinnova for development of the NVP015 genetic mitochondrial disease project
Capital/Financing Update
2017-06-01 English
NeuroVive erhåller forskningsanslag från Vinnova för utveckling av projektet NVP015 för genetisk mitokondriell sjukdom
Capital/Financing Update
2017-06-01 Swedish
NeuroVive kommer att fortsätta den kliniska utvecklingen av NeuroSTAT® efter positivt utfall i prekliniska och kliniska TBI-studier
Regulatory Filings
2017-05-23 Swedish
NeuroVive to continue NeuroSTAT® clinical development after positive outcome in preclinical and clinical TBI studies
Earnings Release FY 2017
2017-05-23 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-05-18 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-05-18 English
NeuroVive inbjuder till telefonkonferens och webbsändning om avtalet med Yungjin Pharm
Report Publication Announcement
2017-05-02 Swedish
NeuroVive invitation to conference call and web cast on in-licensing agreement with Yungjin Pharm
Regulatory Filings
2017-05-02 English
NeuroVive inlicensierar ett kliniskt utvecklingsprojekt för genetiska mitokondriella sjukdomar från Yungjin Pharm
Capital/Financing Update
2017-05-02 Swedish
NeuroVive in-licenses a genetic mitochondrial disease clinical stage project from Yungjin Pharm
Capital/Financing Update
2017-05-02 English
Resolutions from Annual General Meeting in NeuroVive Pharmaceutical AB (publ)
AGM Information
2017-04-27 English
Beslut vid årsstämma i NeuroVive Pharmaceutical AB (publ)
AGM Information
2017-04-27 Swedish
NeuroVive presenterar prekliniska resultat som bekräftar NV556s anti-fibrotiska effekter i NASH
Regulatory Filings
2017-04-20 Swedish
NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects
Regulatory Filings
2017-04-20 English
NeuroVive’s lead NASH project to be presented at The International Liver Congress™
Regulatory Filings
2017-04-05 English
NeuroVives primära NASH-projekt presenteras på The International Liver Congress™
Regulatory Filings
2017-04-05 Swedish
Antal aktier och röster i NeuroVive Pharmaceutical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-03-31 Swedish
Number of shares and votes in NeuroVive Pharmaceutical AB (publ)
Share Issue/Capital Change
2017-03-31 English
NeuroVive Pharmaceutical publicerar årsredovisningen för 2016
Report Publication Announcement
2017-03-23 Swedish
NeuroVive Pharmaceutical AB publishes 2016 Annual report
Report Publication Announcement
2017-03-23 English
NeuroVive utser vetenskapliga rådgivare och ingår forskningsavtal inom NASH och hepatocellulär cancer
Regulatory Filings
2017-02-22 Swedish
NeuroVive appoints recognized scientific advisors and enters research agreements in NASH and hepatocellular carcinoma
Regulatory Filings
2017-02-22 English
Annual Report 2016
Annual Report FY 2016
2017-02-21 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report FY 2016
2017-02-21 English
NeuroVive’s new generation of sanglifehrin-based compounds demonstrate potent inhibitory effects on human hepatocellular cancer cells
Regulatory Filings
2017-02-02 English
NeuroVives nya generation av sanglifehrin-baserade substanser uppvisar starkt hämmande effekt på humana levercancerceller
Earnings Release FY 2017
2017-02-02 Swedish
NeuroVive redirects research resources from Asian subsidiary to parent
Capital/Financing Update
2017-01-25 English
NeuroVive omfördelar forskningsresurser från asiatiskt dotterbolag till moderbolaget
M&A Activity
2017-01-25 Swedish
NeuroVive signs mitochondrial medicine research agreement with US key opinion leader
Regulatory Filings
2017-01-23 English
NeuroVive tecknar samarbetsavtal med väl ansedd amerikansk forskargrupp inom mitokondriell medicin
Regulatory Filings
2017-01-23 Swedish
NeuroVive presenterar positiva prekliniska data i hepatocellulär cancer på HCC Summit
Regulatory Filings
2017-01-19 Swedish
NeuroVive presents positive preclinical data in hepatocellular cancer at HCC Summit
Regulatory Filings
2017-01-19 English
NeuroVive signs collaboration agreement with Karolinska Institutet
Regulatory Filings
2017-01-10 English
NeuroVive skriver samarbetsavtal med Karolinska Institutet
Regulatory Filings
2017-01-10 Swedish
NeuroVive to Present at the 9th Annual Biotech Showcase Conference
Report Publication Announcement
2017-01-03 English
NeuroVive presenterar på 9th Annual Biotech Showcase Conference
Investor Presentation
2017-01-03 Swedish